Skip to main content
Erschienen in: Cancer Immunology, Immunotherapy 12/2015

01.12.2015 | Original Article

Increased tumor infiltration by mucosal-associated invariant T cells correlates with poor survival in colorectal cancer patients

verfasst von: Luciane Zabijak, Christophe Attencourt, Caroline Guignant, Denis Chatelain, Paulo Marcelo, Jean-Pierre Marolleau, Emmanuel Treiner

Erschienen in: Cancer Immunology, Immunotherapy | Ausgabe 12/2015

Einloggen, um Zugang zu erhalten

Abstract

The infiltration of tumors by lymphocytes is a prognosis factor in colorectal cancer (CRC). The magnitude and quality of this infiltration have emerged as important component of the clinical outcome in these patients. Specifically, markers associated with functional cell-mediated immunity, i.e., a Th1 immune response, are independent markers of better prognosis, whereas Th17-associated components are deleterious and correlate with poorer survival. Mucosal-associated invariant T (MAIT) cells are a recently described T cell subset with tissue-homing properties. They display a restricted TCR repertoire specific for widely conserved microbial ligands, and display anti-bacterial properties upon release of Th1-like, Th17-like, and/or cytotoxic granules. MAIT-cell-specific transcripts have been found in kidney and brain cancer, but have not been studies in other sites. In this study, we retrospectively analyzed by confocal microscopy the presence of MAIT cells within colorectal tumors as compared with paired healthy tissues. We observed a significant although variable increase, both in density and in proportion of overall tumor-infiltrating T lymphocytes inside the tumors. Importantly, survival curves as well as multivariate analysis showed that patients displaying a higher recruitment of MAIT cells in their tumor, as compared with the neighboring healthy tissue, showed a less favorable clinical outcome. This study suggests that including MAIT-cell-specific markers or transcripts in the analysis of tumor-infiltrating lymphocytes could be a benefit to the diagnosis and follow-up of CRC patients.
Literatur
1.
Zurück zum Zitat Schreiber RD, Old LJ, Smyth MJ (2011) Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science 331(6024):1565–1570CrossRefPubMed Schreiber RD, Old LJ, Smyth MJ (2011) Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science 331(6024):1565–1570CrossRefPubMed
2.
Zurück zum Zitat Fridman WH, Pages F, Sautes-Fridman C, Galon J (2012) The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 12(4):298–306CrossRefPubMed Fridman WH, Pages F, Sautes-Fridman C, Galon J (2012) The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 12(4):298–306CrossRefPubMed
3.
Zurück zum Zitat Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R et al (2005) Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 353(25):2654–2666CrossRefPubMed Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R et al (2005) Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 353(25):2654–2666CrossRefPubMed
4.
Zurück zum Zitat Siddiqui SA, Frigola X, Bonne-Annee S, Mercader M, Kuntz SM, Krambeck AE et al (2007) Tumor-infiltrating Foxp3−CD4+CD25+ T cells predict poor survival in renal cell carcinoma. Clin Cancer Res 13(7):2075–2081CrossRefPubMed Siddiqui SA, Frigola X, Bonne-Annee S, Mercader M, Kuntz SM, Krambeck AE et al (2007) Tumor-infiltrating Foxp3−CD4+CD25+ T cells predict poor survival in renal cell carcinoma. Clin Cancer Res 13(7):2075–2081CrossRefPubMed
5.
Zurück zum Zitat Sheu BC, Lin RH, Lien HC, Ho HN, Hsu SM, Huang SC (2001) Predominant Th2/Tc2 polarity of tumor-infiltrating lymphocytes in human cervical cancer. J Immunol 167(5):2972–2978CrossRefPubMed Sheu BC, Lin RH, Lien HC, Ho HN, Hsu SM, Huang SC (2001) Predominant Th2/Tc2 polarity of tumor-infiltrating lymphocytes in human cervical cancer. J Immunol 167(5):2972–2978CrossRefPubMed
6.
Zurück zum Zitat Roussel E, Gingras MC, Grimm EA, Bruner JM, Moser RP (1996) Predominance of a type 2 intratumoural immune response in fresh tumour-infiltrating lymphocytes from human gliomas. Clin Exp Immunol 105(2):344–352PubMedCentralCrossRefPubMed Roussel E, Gingras MC, Grimm EA, Bruner JM, Moser RP (1996) Predominance of a type 2 intratumoural immune response in fresh tumour-infiltrating lymphocytes from human gliomas. Clin Exp Immunol 105(2):344–352PubMedCentralCrossRefPubMed
7.
Zurück zum Zitat Li X, Ye DF, Xie X, Chen HZ, Lu WG (2005) Proportion of CD4+CD25+ regulatory T cell is increased in the patients with ovarian carcinoma. Cancer Invest 23(5):399–403PubMed Li X, Ye DF, Xie X, Chen HZ, Lu WG (2005) Proportion of CD4+CD25+ regulatory T cell is increased in the patients with ovarian carcinoma. Cancer Invest 23(5):399–403PubMed
8.
Zurück zum Zitat Kharkevitch DD, Seito D, Balch GC, Maeda T, Balch CM, Itoh K (1994) Characterization of autologous tumor-specific T-helper 2 cells in tumor-infiltrating lymphocytes from a patient with metastatic melanoma. Int J Cancer 58(3):317–323CrossRefPubMed Kharkevitch DD, Seito D, Balch GC, Maeda T, Balch CM, Itoh K (1994) Characterization of autologous tumor-specific T-helper 2 cells in tumor-infiltrating lymphocytes from a patient with metastatic melanoma. Int J Cancer 58(3):317–323CrossRefPubMed
9.
Zurück zum Zitat Asselin-Paturel C, Echchakir H, Carayol G, Gay F, Opolon P, Grunenwald D et al (1998) Quantitative analysis of Th1, Th2 and TGF-beta1 cytokine expression in tumor, TIL and PBL of non-small cell lung cancer patients. Int J Cancer 77(1):7–12CrossRefPubMed Asselin-Paturel C, Echchakir H, Carayol G, Gay F, Opolon P, Grunenwald D et al (1998) Quantitative analysis of Th1, Th2 and TGF-beta1 cytokine expression in tumor, TIL and PBL of non-small cell lung cancer patients. Int J Cancer 77(1):7–12CrossRefPubMed
10.
Zurück zum Zitat Tosolini M, Kirilovsky A, Mlecnik B, Fredriksen T, Mauger S, Bindea G et al (2011) Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Res 71(4):1263–1271CrossRefPubMed Tosolini M, Kirilovsky A, Mlecnik B, Fredriksen T, Mauger S, Bindea G et al (2011) Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Res 71(4):1263–1271CrossRefPubMed
11.
Zurück zum Zitat Lv L, Pan K, Li XD, She KL, Zhao JJ, Wang W et al (2011) The accumulation and prognosis value of tumor infiltrating IL-17 producing cells in esophageal squamous cell carcinoma. PLoS ONE 6(3):e18219PubMedCentralCrossRefPubMed Lv L, Pan K, Li XD, She KL, Zhao JJ, Wang W et al (2011) The accumulation and prognosis value of tumor infiltrating IL-17 producing cells in esophageal squamous cell carcinoma. PLoS ONE 6(3):e18219PubMedCentralCrossRefPubMed
12.
Zurück zum Zitat Kryczek I, Banerjee M, Cheng P, Vatan L, Szeliga W, Wei S et al (2009) Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 114(6):1141–1149PubMedCentralCrossRefPubMed Kryczek I, Banerjee M, Cheng P, Vatan L, Szeliga W, Wei S et al (2009) Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 114(6):1141–1149PubMedCentralCrossRefPubMed
13.
Zurück zum Zitat Chen X, Wan J, Liu J, Xie W, Diao X, Xu J et al (2010) Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients. Lung Cancer 69(3):348–354CrossRefPubMed Chen X, Wan J, Liu J, Xie W, Diao X, Xu J et al (2010) Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients. Lung Cancer 69(3):348–354CrossRefPubMed
14.
Zurück zum Zitat Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C et al (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313(5795):1960–1964CrossRefPubMed Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C et al (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313(5795):1960–1964CrossRefPubMed
16.
Zurück zum Zitat Le Bourhis L, Martin E, Peguillet I, Guihot A, Froux N, Core M et al (2010) Antimicrobial activity of mucosal-associated invariant T cells. Nat Immunol 11(8):701–708CrossRefPubMed Le Bourhis L, Martin E, Peguillet I, Guihot A, Froux N, Core M et al (2010) Antimicrobial activity of mucosal-associated invariant T cells. Nat Immunol 11(8):701–708CrossRefPubMed
17.
Zurück zum Zitat Gold MC, Lewinsohn DM (2013) Co-dependents: MR1-restricted MAIT cells and their antimicrobial function. Nat Rev Microbiol 11(1):14–19CrossRefPubMed Gold MC, Lewinsohn DM (2013) Co-dependents: MR1-restricted MAIT cells and their antimicrobial function. Nat Rev Microbiol 11(1):14–19CrossRefPubMed
18.
Zurück zum Zitat Dusseaux M, Martin E, Serriari N, Peguillet I, Premel V, Louis D et al (2011) Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. Blood 117(4):1250–1259CrossRefPubMed Dusseaux M, Martin E, Serriari N, Peguillet I, Premel V, Louis D et al (2011) Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. Blood 117(4):1250–1259CrossRefPubMed
19.
Zurück zum Zitat Leung DT, Bhuiyan TR, Nishat NS, Hoq MR, Aktar A, Rahman MA et al (2014) Circulating mucosal associated invariant T cells are activated in Vibrio cholerae O1 infection and associated with lipopolysaccharide antibody responses. PLoS Negl Trop Dis 8(8):e3076PubMedCentralCrossRefPubMed Leung DT, Bhuiyan TR, Nishat NS, Hoq MR, Aktar A, Rahman MA et al (2014) Circulating mucosal associated invariant T cells are activated in Vibrio cholerae O1 infection and associated with lipopolysaccharide antibody responses. PLoS Negl Trop Dis 8(8):e3076PubMedCentralCrossRefPubMed
20.
Zurück zum Zitat Grimaldi D, Le Bourhis L, Sauneuf B, Dechartres A, Rousseau C, Ouaaz F et al (2014) Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections. Intensive Care Med 40(2):192–201CrossRefPubMed Grimaldi D, Le Bourhis L, Sauneuf B, Dechartres A, Rousseau C, Ouaaz F et al (2014) Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections. Intensive Care Med 40(2):192–201CrossRefPubMed
21.
Zurück zum Zitat Gold MC, Cerri S, Smyk-Pearson S, Cansler ME, Vogt TM, Delepine J et al (2010) Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol 8(6):e1000407PubMedCentralCrossRefPubMed Gold MC, Cerri S, Smyk-Pearson S, Cansler ME, Vogt TM, Delepine J et al (2010) Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol 8(6):e1000407PubMedCentralCrossRefPubMed
22.
Zurück zum Zitat Willing A, Leach OA, Ufer F, Attfield KE, Steinbach K, Kursawe N et al (2014) CD8(+) MAIT cells infiltrate into the CNS and alterations in their blood frequencies correlate with IL-18 serum levels in multiple sclerosis. Eur J Immunol 44(10):3119–3128CrossRefPubMed Willing A, Leach OA, Ufer F, Attfield KE, Steinbach K, Kursawe N et al (2014) CD8(+) MAIT cells infiltrate into the CNS and alterations in their blood frequencies correlate with IL-18 serum levels in multiple sclerosis. Eur J Immunol 44(10):3119–3128CrossRefPubMed
23.
Zurück zum Zitat Teunissen MB, Yeremenko NG, Baeten DL, Chielie S, Spuls PI, de Rie MA et al (2014) The IL-17A-producing CD8+ T-cell population in psoriatic lesional skin comprises mucosa-associated invariant T cells and conventional T cells. J Invest Dermatol 134(12):2898–2907CrossRefPubMed Teunissen MB, Yeremenko NG, Baeten DL, Chielie S, Spuls PI, de Rie MA et al (2014) The IL-17A-producing CD8+ T-cell population in psoriatic lesional skin comprises mucosa-associated invariant T cells and conventional T cells. J Invest Dermatol 134(12):2898–2907CrossRefPubMed
24.
Zurück zum Zitat Serriari NE, Eoche M, Lamotte L, Lion J, Fumery M, Marcelo P et al (2014) Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases. Clin Exp Immunol 176(2):266–274PubMedCentralCrossRefPubMed Serriari NE, Eoche M, Lamotte L, Lion J, Fumery M, Marcelo P et al (2014) Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases. Clin Exp Immunol 176(2):266–274PubMedCentralCrossRefPubMed
25.
Zurück zum Zitat Miyazaki Y, Miyake S, Chiba A, Lantz O, Yamamura T (2011) Mucosal-associated invariant T cells regulate Th1 response in multiple sclerosis. Int Immunol 23(9):529–535CrossRefPubMed Miyazaki Y, Miyake S, Chiba A, Lantz O, Yamamura T (2011) Mucosal-associated invariant T cells regulate Th1 response in multiple sclerosis. Int Immunol 23(9):529–535CrossRefPubMed
26.
Zurück zum Zitat Peterfalvi A, Gomori E, Magyarlaki T, Pal J, Banati M, Javorhazy A et al (2008) Invariant Valpha7.2-Jalpha33 TCR is expressed in human kidney and brain tumors indicating infiltration by mucosal-associated invariant T (MAIT) cells. Int Immunol 20(12):1517–1525CrossRefPubMed Peterfalvi A, Gomori E, Magyarlaki T, Pal J, Banati M, Javorhazy A et al (2008) Invariant Valpha7.2-Jalpha33 TCR is expressed in human kidney and brain tumors indicating infiltration by mucosal-associated invariant T (MAIT) cells. Int Immunol 20(12):1517–1525CrossRefPubMed
27.
Zurück zum Zitat Greathead L, Metcalf R, Gazzard B, Gotch F, Steel A, Kelleher P (2014) CD8+/CD161++ mucosal-associated invariant T-cell levels in the colon are restored on long-term antiretroviral therapy and correlate with CD8+ T-cell immune activation. AIDS 28(11):1690–1692CrossRefPubMed Greathead L, Metcalf R, Gazzard B, Gotch F, Steel A, Kelleher P (2014) CD8+/CD161++ mucosal-associated invariant T-cell levels in the colon are restored on long-term antiretroviral therapy and correlate with CD8+ T-cell immune activation. AIDS 28(11):1690–1692CrossRefPubMed
28.
Zurück zum Zitat Novak J, Dobrovolny J, Novakova L, Kozak T (2014) The decrease in number and change in phenotype of mucosal-associated invariant T cells in the elderly and differences in men and women of reproductive age. Scand J Immunol 80(4):271–275CrossRefPubMed Novak J, Dobrovolny J, Novakova L, Kozak T (2014) The decrease in number and change in phenotype of mucosal-associated invariant T cells in the elderly and differences in men and women of reproductive age. Scand J Immunol 80(4):271–275CrossRefPubMed
29.
Zurück zum Zitat Wang K, Kim MK, Di Caro G, Wong J, Shalapour S, Wan J et al (2014) Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis. Immunity 41(6):1052–1063CrossRefPubMed Wang K, Kim MK, Di Caro G, Wong J, Shalapour S, Wan J et al (2014) Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis. Immunity 41(6):1052–1063CrossRefPubMed
30.
Zurück zum Zitat Grivennikov SI, Wang K, Mucida D, Stewart CA, Schnabl B, Jauch D et al (2012) Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 491(7423):254–258PubMedCentralPubMed Grivennikov SI, Wang K, Mucida D, Stewart CA, Schnabl B, Jauch D et al (2012) Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 491(7423):254–258PubMedCentralPubMed
31.
Zurück zum Zitat Jess T, Gamborg M, Matzen P, Munkholm P, Sorensen TI (2005) Increased risk of intestinal cancer in Crohn’s disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol 100(12):2724–2729CrossRefPubMed Jess T, Gamborg M, Matzen P, Munkholm P, Sorensen TI (2005) Increased risk of intestinal cancer in Crohn’s disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol 100(12):2724–2729CrossRefPubMed
Metadaten
Titel
Increased tumor infiltration by mucosal-associated invariant T cells correlates with poor survival in colorectal cancer patients
verfasst von
Luciane Zabijak
Christophe Attencourt
Caroline Guignant
Denis Chatelain
Paulo Marcelo
Jean-Pierre Marolleau
Emmanuel Treiner
Publikationsdatum
01.12.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Cancer Immunology, Immunotherapy / Ausgabe 12/2015
Print ISSN: 0340-7004
Elektronische ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-015-1764-7

Weitere Artikel der Ausgabe 12/2015

Cancer Immunology, Immunotherapy 12/2015 Zur Ausgabe

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.